Yoelys Cruz-Leal

10PUBLICATIONS
25CO-AUTHORS
Foetal development and medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityImmunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 10, 2026
Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

|Feb 08, 2024
Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP.

Lazaro Gil Gonzalez, Kevin D Won, Zoya Tawhidi

|Nov 10, 2023
Trogocytosis drives red blood cell antigen loss in association with antibody-mediated immune suppression.

Yoelys Cruz-Leal, Peter A A Norris, Lazaro Gil Gonzalez

|Feb 21, 2023
Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine model.

Hanna Wabnitz, Yoelys Cruz-Leal, Alan H Lazarus

|Jan 02, 2023
Antigen-specific IgG subclass composition in recipient mice can indicate the degree of red blood cell alloimmunization as well as discern between primary and secondary immunization.

Hanna Wabnitz, Yoelys Cruz-Leal, Alan H Lazarus

|Dec 14, 2022
THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets.

Lazaro Gil Gonzalez, Yuniel Fernandez-Marrero, Peter Alan Albert Norris

Pageof 2

Frequent Collaborators

6 joint publications

Alan H Lazarus

4 joint publications

Lazaro Gil Gonzalez

3 joint publications

Hanna Wabnitz

2 joint publications

Ulrich J Sachs